NDC 68084-112-11
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-112
- Requested NDC
- 68084-112-11
- Package NDCs from labels
- 68084-112-11
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-112-01 | EA - Each | 68084-112 | be17f831-c22e-452a-88b4-71f3a954a1a9 | 1 | 2012-07-24 |
| 68084-112-11 | EA - Each | 68084-112 | 91eaf166-7d59-4e05-9ea0-a32ef6f163bb | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Moxifloxacin Hydrochloride | MOXIFLOXACIN HYDROCHLORIDE | American Health Packaging | 1ed191f5-7df5-488c-bb72-91ac0b618d9a | 2026-07-02 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Glipizide | GLIPIZIDE | REMEDYREPACK INC. | c2aadc88-22d2-467c-b2cb-03efb5a1f1c1 | 2026-07-02 | Warnings, Adverse reactions | Glipizide GLIPIZIDE |
| Fenofibrate | FENOFIBRATE | American Health Packaging | 8b4488f4-bef6-408c-9fca-3e4aebceff9a | 2026-07-02 | Warnings, Adverse reactions | American Health Packaging |
| Metoprolol Tartrate | METOPROLOL TARTRATE | American Health Packaging | 0a3ccfd4-8b65-4c7e-b0ba-27ff40d5b5e8 | 2026-07-02 | Warnings, Adverse reactions | American Health Packaging |
| Oxcarbazepine | OXCARBAZEPINE | American Health Packaging | c0f9df3f-280e-4394-8d7e-ad04803b2635 | 2026-07-02 | Warnings, Adverse reactions | American Health Packaging |
| Mirtazapine | MIRTAZAPINE | American Health Packaging | 82a615a0-e74a-49cb-9a57-ffbb3df604d5 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Diclofenac Sodium | DICLOFENAC SODIUM | American Health Packaging | dbb1489d-b690-4e53-905d-7fb07ad263b3 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | American Health Packaging | f7004cbd-9827-466e-9683-adce4f13c6a6 | 2026-07-01 | Warnings, Adverse reactions | American Health Packaging |
| Methylprednisolone | METHYLPREDNISOLONE | American Health Packaging | 97256c7e-5694-4148-926f-594b9d5c34f4 | 2026-07-01 | Warnings, Adverse reactions | American Health Packaging |
| Metoprolol Succinate | METOPROLOL SUCCINATE | American Health Packaging | 74e3b4dc-eb30-4d7c-a558-cf58f6470496 | 2026-06-30 | Warnings, Adverse reactions | American Health Packaging |
| Sevelamer Hydrochloride | SEVELAMER HYDROCHLORIDE | American Health Packaging | 8830526f-d957-423e-84ea-e4d79346948b | 2026-06-25 | Warnings, Adverse reactions | American Health Packaging |
| Atomoxetine | ATOMOXETINE | American Health Packaging | 10d36b32-0202-4c03-8a1a-cd5d53f231e7 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | be7cab51-ce7e-465d-95db-083e69288cfd | 2026-06-25 | Warnings | American Health Packaging |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | American Health Packaging | 9f015e60-1aec-4ae7-b28f-42f6c8f50455 | 2026-06-25 | Warnings, Adverse reactions | American Health Packaging |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | American Health Packaging | 0c71bdfb-01db-49ac-a8e9-0037df0d24af | 2026-06-24 | Warnings, Adverse reactions | American Health Packaging |
| Valganciclovir | VALGANCICLOVIR | American Health Packaging | 4db6dd63-e56b-45a4-86b2-ee125a1854a0 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | American Health Packaging | 88c980c8-aaa8-4378-9ac2-24d588640caa | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Glipizide | GLIPIZIDE | American Health Packaging | ff6805bb-b5f0-46d3-bf1d-3333b63ff1ae | 2026-06-24 | Warnings, Adverse reactions | Glipizide GLIPIZIDE American Health Packaging |
| Losartan Potassium | LOSARTAN POTASSIUM | American Health Packaging | e7f6b25b-ec4c-4c3a-a541-617d2d9ab393 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
| Midodrine Hydrochloride | MIDODRINE HYDROCHLORIDE | American Health Packaging | 159cb0cb-4b27-4a1c-8ad4-dc93604c79c7 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | American Health Packaging |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.